HCV protein-induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection

被引:0
|
作者
Krueger, Carla [1 ,2 ]
Collister, Mark [1 ,2 ]
Minuk, Gerald Y. [1 ]
Janke, Alyssa [1 ]
Lerner, Jordyn [1 ]
Wong, Stephen G. M. [1 ]
Rempel, Julia D. [1 ,2 ]
机构
[1] Univ Manitoba, Dept Med, Sect Hepatol, Winnipeg, MB R3E 3P4, Canada
[2] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 3P4, Canada
关键词
adipokines; core; hepatitis C virus; NS3; sustained viral response; TNF-alpha; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; RHEUMATOID-ARTHRITIS; SERUM-LEVELS; PSORIATIC-ARTHRITIS; ETANERCEPT THERAPY; ADIPONECTIN LEVELS; EGYPTIAN PATIENTS; INTERFERON-ALPHA; LIVER STEATOSIS;
D O I
10.1111/liv.12418
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Immune-mediated processes are thought to influence the efficacy of treatment in chronic hepatitis C virus (HCV) infection. This study evaluated the association of baseline immune responses with the achievement of a sustained viral response (SVR) upon pegylated interferon and ribavirin treatment. Methods: Baseline serum and peripheral blood mononuclear cells (PBMC) cytokine activity was assessed. Metabolic and liver injury parameters were evaluated as underlying factors. Results: Baseline demographics and disease parameters did not differ between the SVR - (n = 14) and SVR+ (n = 25) cohorts except for body mass index (BMI) values and liver injury scores. Baseline circulating TNF-alpha levels were three-fold higher with subsequent treatment failure vs. success (P = 0.124). Baseline peripheral blood mononuclear cells (PBMC, n = 25) were cultured with HCV core and non-structural (NS)3 proteins. Core (P = 0.0003) and NS3 (P = 0.018) induced greater TNF-alpha production within the SVR-, compared with the SVR+, cohorts. Similar findings were noted for interleukin (IL)-1 beta and IL-10 synthesis. Furthermore, HCV core-induced TNF-alpha synthesis correlated with patient BMI values (r = 0.489, P = 0.015). Core (r = 0.432, P = 0.065) and NS3 (r = 0.530, P = 0.020)-induced TNF-alpha displayed a positive relationship with serum adiponectin concentrations. In addition, lipopolysaccharide stimulated cytokine synthesis associated with BMI and adiponectin levels. Although unable to predict treatment outcomes, NS3-induced IL-6 synthesis and serum leptin concentrations corresponded to liver injury scores. Conclusion: An enhanced PBMC susceptibility to core and NS3-induced TNF-alpha synthesis at baseline was associated with treatment failure. This phenomenon appeared to involve the interaction of virally generated TNF-alpha activity and metabolic disease. In contrast, IL-6 activity and leptin levels may indicate liver damage.
引用
收藏
页码:E62 / E70
页数:9
相关论文
共 50 条
  • [21] Disease Burden of Chronic Hepatitis C Virus (HCV) Infection in India
    Puri, Pankaj
    Anand, Anil C.
    Saraswat, Vivek A.
    Acharya, Subrat K.
    Sarin, Shiv K.
    Dhiman, Radha K.
    Aggarwal, Rakesh
    Singh, Shivaram P.
    Amarapurkar, Deepak N.
    Arora, Anil
    Chhabra, Mohinish
    Chetri, Kamal
    Choudhuri, Gourdas
    Chowdhury, Abhijit
    Dixit, Vinod K.
    Duseja, Ajay K.
    Blach, Sarah
    Jain, Ajay K.
    Kapoor, Dharmesh
    Kar, Premashis
    Koshy, Abraham
    Kumar, Ashish
    Madan, Kaushal
    Misra, P.
    Prasad, Mohan V.
    Nagral, Aabha
    Puri, Amarendra S.
    Ramachandran, Jeyamani
    Razavi, Homie
    Saigal, Sanjiv
    Shah, Samir R.
    Sharma, Praveen K.
    Sood, Ajit
    Thareja, Sandeep
    Wadhawan, Manav
    HEPATOLOGY, 2014, 60 : 937A - 938A
  • [22] THE DISEASE BURDEN OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN SWITZERLAND
    Bruggmann, P.
    Negro, F.
    Bihl, F.
    Hindman, S.
    Lavanchy, D.
    Muellhaupt, B.
    Razavi, H.
    Semela, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S518 - S518
  • [23] Cytokine response to hepatitis C virus core peptides in patients with chronic hepatitis C infection and healthy anti-HCV seropositives.
    Woitas, RP
    Lechmann, M
    Langhans, B
    Bar, S
    Ihlenfeldt, HG
    Jung, G
    Sauerbruch, T
    Spengler, U
    HEPATOLOGY, 1996, 24 (04) : 558 - 558
  • [24] CYTOKINE PROFILES IN CHRONIC HEPATITIS C VIRUS AND CHRONIC HEPATITIS B VIRUS INFECTION WITH HIGH VIRAL LOADS
    Kishida, Yutaka
    HEPATOLOGY, 2019, 70 : 1008A - 1009A
  • [25] GENDER DIFFERENCES ON LONG-TERM OUTCOMES IN PATIENTS WITH DUAL CHRONIC HEPATITIS B VIRUS (HBV) AND CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
    Shah, Sonia
    Nguyen, Pauline
    Le, An K.
    Zhao, Changqing
    Hoang, Joseph
    Yasukawa, Lee Ann
    Weber, Susan C.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1171 - S1171
  • [26] Gender differences on long-term outcomes in patients with dual chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infection
    Shah, S.
    Nguyen, P.
    Le, A. K.
    Zhao, C.
    Hoang, J.
    Yasukawa, L. A.
    Weber, S. C.
    Nguyen, M. H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S707 - S708
  • [27] GEOGRAPHICAL HETEROGENEITY OF HEPATITIS-C VIRUS (HCV) INFECTION IN AUTOIMMUNE CHRONIC HEPATITIS
    LENZI, M
    JOHNSON, PJ
    MCFARLANE, IG
    SMITH, H
    VERGANI, D
    BIANCHI, F
    WILLIAMS, R
    GUT, 1991, 32 (07) : A839 - A840
  • [28] High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection
    Wang, CC
    Morishima, C
    Chung, MJ
    Engelberg, R
    Krantz, E
    Krows, M
    Sullivan, DG
    Gretch, DR
    Corey, L
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (05): : 672 - 676
  • [29] OPTIMISING TREATMENT OUTCOMES IN CHRONIC HEPATITIS C VIRUS INFECTION BY IMPROVING TREATMENT ADHERENCE RATES
    Campbell, L.
    Cook, N.
    Roguin, T.
    Marcinkowski, H.
    Tooley, V.
    Gellissen, R.
    Brown, A.
    Main, J.
    Thomas, H. C.
    Thursz, M. R.
    GUT, 2010, 59 : A78 - A79
  • [30] Amantadine in treatment of chronic hepatitis C virus infection?
    Lim, JK
    Wooten, D
    Siegel, R
    Cheung, RC
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) : 445 - 455